Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-03-28
1998-09-29
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5483037, 5483041, A61K 31415
Patent
active
058146504
ABSTRACT:
Described herein are biotin amides which are able to control glucidic metabolism under dysmetabolic conditions and relative therapeutical compositions for the treatment of insulin-independent diabetes, insulin-dependent diabetes and relative complicating diseases, such as peripheral neuropathies and other associated chronic invalidating disorders.
REFERENCES:
patent: 2519530 (1950-08-01), Wolf et al.
patent: 4054740 (1977-10-01), Field
patent: 4709037 (1987-11-01), Sigler
patent: 4908453 (1990-03-01), Cocuzza
Green, N.M.; Konieczny, L.; Toms, E.J. and Valentine, R.C. Biochem. J. (1971) vol. 125, pp. 781-791.
Jasbir Chauhan and Krishnamurti Dakshinamurti, Transcription Regulation of the Glucokinase Gene by Biotin in Starved Rats, The Journal of Biological Chemistry, vol. 266, No. 16, Jun. 1991, pp. 10035-10038.
John C. Coggeshall et al, Biotin Status and Plasma Glucose in Diabetics, N.Y. Acad. Sci. 447, 1985, pp. 389-392.
A. Reddi et al, Biotin Supplementation Improves Glucose and Insulin Tolerances in Genetically Diabetic KK Mice, Life Sciences, vol. 42, 1988, pp. 1323-1330.
Roth, Karl S., Biotin in Clinical Medicine--A Review, The American Journal of Clinical Nutrition 34: Sep. 1981, pp. 1967-1974.
Krishnamurti Dakshinamurti and Jasbir Chauhan, Biotin, Vitamins and Hormones, vol. 45, 1989, pp. 337-385.
K. Dakshinamurti and C. Cheah-Tan, Biotin-Mediated Synthesis of Hepatic Glucokinase in the Rat, Archives of Biochemistry and Biophysics 127, 1968, pp. 17-21.
D. Koutsikos et al, Biotin for Diabetic Peripheral Neuropathy, Biomed & Pharmacother, 1990, 44, pp. 511-514.
Thomas Kempe et al, Chemical and Enzymatic Biotin-Labeling of Oligodeoxyribo-nucleotides, Nucleic Acids Research, vol. 13, No. 1, 1985, pp. 45-57.
Marlon M. Bradford, A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding, Analytical Biochemistry 72, 1976, pp. 248-254.
Hanssen et al, "Diabetic Control and Microvascular Complications: The Near-Normoglycaemic Experience", Diabetologia 29: 677-684 (1986).
Chapter 34 in "Remington's Pharmaceutical Sciences" (The Philadelphia College of Pharmacy and Science, 1990) pp. 682-683.
Shami et al, "Microangiopathy in Diabetes Mellitus: II Features, Complications and Investigation", Diabetes Research, 17, 157-158 (1991) pp. 157-168.
Chapter 2.20 in Vogel's Textbook of Practical Organic Chemistry, Fifth Ed., Longman Group UK, 1989) pp. 135-136.
"Peripheral Neuropathies", World Health Organization (WHO), Technical Report Series 654 (1980), pp. 88-93.
Krishnamurti Dakshinamurti et al, "Biotin" in Vitamins and Hormones Advances in Research and Applications, vol. 45, Ed. by Aurbach and McCormick, Academic Press, Inc. (1989), pp. 337-384.
Patent Abstracts of Japan, vol. 4, No. 85 (C-015) 18 Jun. 1980 & JP-A-55 050 863 (Sumitomo Chem. Co., Ltd.) 14 Apr. 1980.
Patent Abstracts of Japan, vol. 16, No. 470 (C-0990) 30 Sep. 1992 & JP-A-04 169 528 (tanabe seiyaku co. ltd.) 17 Jun. 1992.
Heiko J. Luhmann and Uwe Heinemann, Journal of Neurophysiology, Apr. 1992, vol. 67, No. 4, pp. 798-811.
Green et al, Biochem J., (1971), vol. 123 pp. 781-791.
della Valle Francesco
Galzigna Lauro
Lorenzi Silvana
Marcolongo Gabriele
Lifegroup S.P.A.
Richter Johann
Stockton Laura L.
LandOfFree
Biotin amides able to control glucidic metabolisms under dysmeta does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biotin amides able to control glucidic metabolisms under dysmeta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biotin amides able to control glucidic metabolisms under dysmeta will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-686665